drugdeliverybusiness22h
Senseonics reports mixed Q3 results, positive Eversense 365 outlook
Senseonics (NYSE:SENS) shares dipped slightly before hours today on third-quarter results that came in mixed compared to the consensus forecast. Shares of SENS fell 2.5% to 34¢ apiece in pre-market ...
drugdeliverybusiness1d
Insulet stock rises on Q3 beat, raised sales guidance
Insulet (Nasdaq:PODD) shares ticked up today on third-quarter results that came in well ahead of the consensus forecast.
drugdeliverybusiness2d
Tandem stock rises on 31% Q3 sales growth, raised guidance
Tandem Diabetes Care shares ticked up after hours today on third-quarter results that topped the consensus forecast.
drugdeliverybusiness2d
Insulin pump maker PharmaSens adds former ADA leaders, medtech veterans to board
PharmaSens announced today that it appointed Dr. Robert A. Gabbay and James L. Peterson to its board of directors.
drugdeliverybusiness7d
Medtronic kicks off Blue Balloon Challenge for National Diabetes Awareness Month
Que Dallara, EVP and president of Medtronic Diabetes, wrote on LinkedIn: ...
drugdeliverybusiness7d
Insulet announces diabetes awareness initiatives for November
Insulet (Nasdaq:PODD) today announced its plans to recognize National Diabetes Awareness Month and World Diabetes Day.
drugdeliverybusiness9d
FDA approves Abbott CGMs for use during medical imaging
Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.
drugdeliverybusiness9d
Beta Bionics launches iLet bionic pancreas with Abbott FreeStyle Libre 3 Plus
Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...